series-c-plus
Stage
1
Investors
About
Intervacc is a Swedish biotechnology company that develops recombinant protein-based vaccines to improve animal health and welfare by protecting against bacterial infections.
Explore Intervacc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.